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In order to examine the effectiveness of applying a static magnetic field (SMF) for increasing bone
mineral density (BMD), we assessed the degree of osteopenia by dual-energy X-ray absorptiometry
(DEXA), the metabolism measuring system, and histological examination of bone tissue in an
ovariectomized (OVX) rat model. Thirty-six female Wistar rats (8 weeks old, 160–180 g) were divided
into three groups. The rats in the OVX-M group were exposed to SMF for 12 weeks after ovariectomy.
The ovariectomized rats in the OVX-D group were not exposed to SMF as a control. The rats in the
normal group received neither ovariectomy nor exposure to SMF. Twelve-week exposure to SMF in
the OVX-M group inhibited the reduction in BMD that was observed in the OVX-D group. Moreover, in
the OVX rats, before exposure to SMF, there was no clear difference in the level of locomotor activity
between the active and resting phases, and the pattern of locomotor activity was irregular. After
exposure of OVX rats to SMF, the pattern of locomotor activity became diphasic with clear active and
resting phases, as was observed in the normal group. In the OVX-M group, the continuity of the
trabecular bone was maintained more favorably and bone mass was higher than the respective
parameters in the OVX-D group. These results demonstrate that exposure to SMF increased the level of
locomotor activity in OVX rats, thereby increasing BMD.
Keywords: locomotor activity – ovariectomized (OVX) rat – static magnetic fields (SMF) –
thermography
Introduction
The biological response to exposure to static magnetic field
(SMF) has recently been widely discussed from the perspec-
tive of possible health benefits as well as potential adverse
effects. With respect to the possible health benefits, it has been
reported that local SMF stimulation is beneficial for pain,
nerve regeneration (1), imflammation (2), blood flow (3) and
united fractures (4). SMF has been used to provide pain relief
from neck and shoulder pain and knee pain due to ischemic
conditions of the blood microcirculation (5–7).
Osteoporosis patients with climacteric disturbance are
frequently encountered in Oriental medicine clinics, but their
osteoporosis is rarely treated. The ovariectomized (OVX) rat
has been usually used as a model of osteopenia to study
climacteric disturbance (8).
After menopause or ovariectomy, women tend to develop
osteopenia and menopausal symptoms, including hot flashes,
abnormal feelings, palpitations and insomnia. In particular,
ovariectomy before menopause has been reported to cause
osteoporosis and severe menopausal symptoms because of
sudden estrogen deficiency (9–11). It has recently been
reported that application of SMF is useful for the treatment
of a decrease in bone mineral density (BMD) (12,13).
In a previous study, we found that traditional Chinese
medicine alternative climacteric disturbance and inhibited the
decrease in BMD observed in post-menopausal women.
In the present study, we exposed OVX rats, which served as
an experimental osteopenia model, to SMF and obtained
interesting findings.
For reprints and all correspondence: N. Taniguchi, Kansai college of Oriental
Medicine, 2-11-1 Wakaba Kumatori-cho, Sennan-gun, Osaka 590-0482,
Japan. Tel: þ81-724-53-8251; Fax: þ81-724-53-0276;
E-mail: kanai@kansai.ac.jp
 2006 The Author(s).
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Materials and Methods
Study Animals and Environmental Conditions
This study was approved by the Animal Committee of Kansai
College in Osaka, Japan. Female Wistar rats (age, 7 weeks;
body weight,  150 g) were purchased from Japan Crea Co.,
Ltd (Shizuoka, Japan). The animals were housed individually
in cages and kept in a room maintained at a temperature of
23.0 ± 1.0 C with a relative humidity (RH) of 55.0 ± 5.0% and
a 12 h/12 h light-dark cycle (light, 9:00 a.m.–9:00 p.m.). Solid
rodent chow and tap water were given ad libitum. After 1 week
of acclimation under these conditions, animals showing
favorable growth were selected and used for further studies.
Experimental Groups
Thirty-six rats aged 8 weeks were divided into 3 groups of 12
rats each. The rats in the OVX-M group underwent ovar-
iectomy at 8 weeks of age and then, starting at 12 weeks of age,
they underwent 12 week exposure to SMF. The rats in the
OVX-D group underwent ovariectomy at 8 weeks of age and
were not subsequently exposed to SMF. The rats in the normal
group did not undergo ovariectomy or exposure to SMF.
Experimental Schedule and Conditions for Exposure
In the OVX-M group, two 200 mT magnets (Pip-Fujimoto Co.,
Ltd, Osaka, Japan) were fixed along opposite sides of the cage
(there was an average of 30 mT of magnetic force at the center
of the cage), and each rat was exposed to SMF all day for
12 weeks (Fig. 1A–C). In the OVX-D group, which was the
control group, two 0 mT magnetic stones were similarly
placed, and no magnetic field was applied.
After ovariectomy, the rats in the OVX-M and OVX-D
groups were not exposed to the respective magnetic stones for
4 weeks; then, the respective magnetic stones were placed
along opposite sides of the cage of each rat for 12 weeks.
Observations
Measurement of Body Weight (BW), Serum Total
Cholesterol (T-chol) Level and Urinary Deoxypyridinoline
(Dpd) Level Before and After 12 weeks of Exposure to SMF
The BW of each rat was measured before and after 12 weeks of
exposure to SMF in the OVX-M group, and at the respective
time points in the OVX-D and normal groups. Blood samples
(1.5 mL) were collected from the cervical vein under ether
anesthesia, and the serum T-chol level was determined using
the Serum Test Kit (Wako Pure Chemicals Industry Ltd,
Wakayama, Japan).
Measurement of Tail Surface Temperature Before and After
Exposure to SMF
The tail surface temperature was measured using a thermo-
graph (TVS-2300 MkIIST, Japan Abionics Co., Ltd, Tokyo,
Japan) in all rats. To avoid the influence of the haircoat, the tail
temperature, which is used as an indicator of the peripheral
circulation, was measured (14). The tail surface temperature
was measured before and after 12 weeks of exposure to SMF in
the OVX-M group, and at the respective time points in the
OVX-D and normal groups. After 15 min of acclimation to
the environment of a windless room maintained at a
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Figure 1. Schematic diagram of magnet show its top plan view (A) and photograph (B). The mean magnetic force at the center of the cage was 30 mT (C).
100 Efficacy of static magnetic fieldtemperature of 15.0 ± 1.0 C and a relative humidity of
50.0 ± 10.0%, the tail surface temperature was measured in
conscious animals. The thermography device was at a distance
of 1 m from the rat during measurement of the tail surface
temperature.
Measurement of Locomotor Activity Before and After
Exposure to SMF
The level of locomotor activity was measured using a
metabolism measuring system (SCANET MV-10; MEL-
QUEST Toyama, Japan). Locomotor activity was measured
over a 24 hour period (1 day) before starting magnetic
stimulation and after 12 weeks of exposure to SMF in the
OVX-M group, and at the respective time points in the OVX-D
and normal groups. The level of total locomotor activity at
30 min intervals was shown graphically over a 24 hour period
and this was used as the daily behavioral pattern (Fig. 2). The
daily locomotor activity was defined as the total locomotor
activity over a 24 hour period. The level of locomotor activity
in the daytime (9:00 a.m.–9:00p.m.) and nighttime (9:00 p.m.–
9:00 a.m.) was measured (15).
Measurement of Bone Mineral Density (BMD), Bone area
and Urinary Deoxypyridinoline (Dpd) Level
After 12 week exposure to SMF in the OVX-M group and at
the respective time points in the OVX-D and normal groups,
all rats were sacrificed and their tibia bones were removed.
The BMD was measured by dual-energy X-ray absorptiometry
(DEXA) using the DCR-600R Dichroma scan (Aloca Co.,
Ltd, Tokyo, Japan). Histological examination of the tibia
bones was performed as described by Ueno (16), and
morphological measurements were made (17). Urine samples
were collected by pooling for 24 hours using rat metabolic
cages, and the urinary level of Dpd was measured by the Elisa
method (18).
Statistical Analysis
The data obtained in each group are expressed as mean ±
standard error. The significance of time-related differences
between the groups was assessed by the Wilcoxon rank sum
test, and the level of significance was set at P < 0.05.
Results
Changes in BW and T-chol Level Before and After
Exposure to SMF
Before exposure to SMF, BW and serum T-chol levels at
12 weeks were higher in the OVX-M and OVX-D groups than
in normal group (P < 0.001), suggesting a tendency of obesity
in animals in the OVX-M and OVX-D groups (Figs 3 and 4).
Changes in Tail Surface Temperature Before and After
Exposure to SMF
Before exposure to SMF, the tail surface temperature was
significantly lower in the OVX-M and OVX-D groups than in
the normal group (P < 0.0001). After 12 weeks of exposure to
SMF, there was no significant difference in the tail surface
temperature between the OVX-M group and normal group
(Fig. 5).
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Figure 2. Locomotor activity system.
eCAM 2007;(4)1 101Changes in Locomotor Activity Before and After
Exposure to SMF
Before exposure to SMF, in the normal group, the pattern of
locomotor activity was regular. In the OVX-M and OVX-D
groups, there was no clear difference in the pattern of
locomotor activity between the active and resting phases and
the pattern of locomotor activity was irregular. After exposure
of the OVX-M group to SMF, the pattern of locomotor activity
became diphasic with clear active and resting phases, similar
to that observed in the normal group (Fig. 6).
Moreover, the daily level of locomotor activity at 12 weeks
was significantly higher in the normal group than in the OVX-
D group (P < 0.01). The daily level of locomotor activity at 12
weeks of age after exposure to SMF in the OVX-M group was
significantly higher than that in the OVX-D group (P < 0.01)
(Fig. 7).
Change in BMD, Bone area and Urinary
Dpd Level (Table 1)
After 12 weeks of exposure to SMF, urinary Dpd levels were
high and bone resorption was significantly enhanced in OVX-
D group compared with the normal group. BMD was
significantly lower in the OVX-M and OVX-D groups than
in the normal group (P < 0.01) (P < 0.001) (Table 1).
However BMD was significantly higher in the OVX-M group
than in the OVX-D group (P < 0.0001).
Histological findings of osteoporosis were observed in the
OVX-D group. In the OVX-M group, the continuity of the
trabecular bone was maintained more favorably and the bone
area of the OVX-M group was higher than that of the OVX-D
group (P < 0.001). The urinary Dpd level was also higher in
the OVX-M group than in the normal group (P < 0.01), but it
was significantly lower in the OVX-M group than in the
OVX-D group (P < 0.05) (Table 1).
Discussion
Patients with climacteric disturbance with osteoporosis are
frequently encountered in the orthopedics clinic, but the
effects of static magnetic therapies on climacteric disturbance
symptoms have rarely been investigated.
On the other hand, OVX rats have been widely studied and
are used as a model of osteopenia and climacteric disturbance
since they have reduced secretion of estrogens due to
ovariectomy. Estrogens induce the growth of reproductive
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Figure 3. Changein BW of OVX andnormal ratsbeforeand after 12 weeksof
exposure to SMF. OVX-D and normal groups were not exposed to SMF.
Significant difference from normal group, mean ± SEM. **P<0.01.
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Figure 4. Change in Serum T-Chol of OVX and normal rats before and after
12 weeks of exposure to SMF. OVX-D and normal groups were not exposed to
SMF. Significant difference from normal group, mean ± SEM. **P<0.01.
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Figure 5. Change in tail surface temperature of OVX and normal rats before
and after 12 weeks of exposure to SMF. OVX-D and normal groups were not
exposed to SMF. Significant difference from normal group, mean ± SEM.
***P<0.001. Significant difference from OVX-M group, mean ± SEM.
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102 Efficacy of static magnetic fieldorgans and the proliferation of mammary glands, facilitate Ca
deposition to bones and reduce serum T-chol level. Therefore,
a variety of symptoms are induced when there is a deficiency
of estrogens (19,20).
In the present study, the serum T-chol level increased in the
OVX-M and OVX-D groups after ovariectomy, indicating a
possible decreased secretion of estrogens. The urinary Dpd
level directly reflects bone resorption and is a good index for
the following reasons: Dpd is released in association with the
decomposition of type I collagen during bone resorption; it is
not released at the time of bone formation; the Dpd level is not
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Figure 6. Change of locomotor activity of OVX-M, OVX-D and normal groups 24 hours of exposure to SMF. In OVX rats, before exposure to SMF, there was no
clear difference between the active and resting phases, and the pattern of activity was irregular. After exposure, the pattern of activity became diphasic, with clear
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Figure 7. Change in locomotor activity of OVX and normal rats before and
after 12 weeks of exposure to SMF. OVX-D and normal groups were not
exposed to SMF. Significant difference from normal group, mean ± SEM.
*P<0.05, **P<0.01. Significant difference from OVX-M group, mean ±
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Table 1. BMD, bone area and urinary Dpd level in OVX and normal rats
after 12 week exposure to SMF
Bone mineral
density (g cm
 2)
Bone area (%) Urinary Dpd levels
(nmol per mmol Cre)
OVX-M 154.3 ± 2.1†††** 32.7 ± 2.4†††* 116.2 ± 14.8
††
OVX-D 136.4 ± 3.5*** 17.9 ± 2.9*** 139.6 ± 13.6*
Normal 179.8 ± 2.5 50.7 ± 5.8 82.4 ± 6.0
OVX-D and normal groups were not exposed to SMF. Significant difference
from the normal group, mean ± SEM. *P<0.05, **P<0.01, ***P<0.001.
Significant difference from OVX-M group, mean ± SEM.
††P<0.01,
†††P<0.001.
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without being metabolized. Because the urinary Dpd levels
were higher in the OVX-M and OVX-D groups after
ovariectomy than in the normal group, it was confirmed that
bone resorption was enhanced by ovariectomy.
The tail surface temperature of OVX rats showed a clear rise
after prolonged exposure to SMF for 12 weeks, suggesting that
exposure to SMF improves peripheral circulation. Using a
metabolism measuring system, it was confirmed that in
ovariectomized rats, the locomotor activity was higher after
12 weeks of exposure to SMF than before exposure.
Furthermore, it has been reported that SMF therapy relieved
pain in patients with frozen shoulder and low back pain (21).
Therefore, the increase in locomotor activity was presumably
ascribable to the removal of pain rather than to the induction of
stress by SMF.
The mechanism of action of SMF may be as follows: the
magnetic force increases the release of acetylcholine (ACh)
from cholinergic vasodilator nerve endings by inhibiting the
effect of cholinesterase, resulting in vasodilation. In other
words, the recovery of circulation might cause some effects by
altering BMD.
The effects of application of a 1 mT SMF for 10 min on the
cutaneous microcirculatory system included enhanced vasodi-
latation with increased vasomotion under noradrenaline-
induced high vascular tone, and vasoconstriction with reduced
vasomotion under ACh-induced low vascular tone. Briefly,
these phenomena suggest that SMF can modulate vascular
tone due to the biphasic modification of vasomotion in
cutaneous tissue (22).
A 130 mT (Ferrite) magnet was externally attached to neck
and shoulder continuously for up to 3 weeks. The subchronic
effects caused by continuous exposure to 130 mT for 3 weeks
included significantly enhanced long-lasting vasodilatation in
accordance with increased vasomotion compared with the
control (sham exposure) group that had been exposed to
dummy magnets (23).
We previously reported that administration of oriental
medicine for the treatment of menopausal symptoms in post-
menopausal women improved the menopausal symptoms and
inhibited the reduction in BMD (24). In the present study, after
exposure to SMF, the irregular pattern of locomotor activity of
ovariectomized rats changed to a night-day diphasic pattern as
was observed in the normal rats, and there was a significant
increase in overall locomotor activity.
Physical therapy including therapeutic exercise of bone was
reported to be very effective for osteoporosis (25). Briefly,
since the dynamic exercise of bone is considered to improve
the bone structure and increase BMD, physical therapy is
generally preferable to drug therapy, which may cause side
effects. In Japanese individuals, it was confirmed by a
quantitative ultrasound method that BMD among people who
habitually exercised was significantly higher than that among
people who ate nutritious foods but did not exercise (26).
These results suggest that the increased BMD in the OVX-M
group was partially ascribable to increased locomotor activity.
However, the possibility that SMF directly affects the bone
cannot be ruled out.
Although BMD may increase to some extent by application
of SMF, BMD may not necessarily be markedly increased by it
alone. We consider it important to combine application of
SMF with Western medicine or exercise therapy.
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